Hrt Financial LP Axcella Health Inc. Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.06 - $3.61 $76,512 - $134,082	-37,142 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.98 - $4.31 $20,120 - $29,101	-6,752 Reduced 15.38%	37,142 $110,000
Q2 2021 Aug 16, 2021	BUY	$3.08 - $5.13 $135,193 - $225,176	43,894 New	43,894 $176,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.